文献检索

查找使用阿拉丁产品的科研文献

检索与阿拉丁产品相关的同行评审论文、DOI、PubMed 编号、期刊、作者、CAS 号及研究领域。

科研影响力快照

与阿拉丁产品相关的已发表科研成果

在搜索之前,这些指标可帮助访客快速了解产品关联科研的规模与质量。

346,364+ SCI 论文 与阿拉丁产品引用相关
2,295,288.15 总影响因子 匹配文献记录中影响因子的总和
81.20 最高期刊影响因子 匹配期刊中的最高 IF
6.63 平均期刊影响因子 匹配文献的平均 IF

参考指标 指标基于阿拉丁文献引用数据库及期刊影响因子记录。文献关联仅供科研参考,请以原始文献为准。

热门产品

视图 列表 网格

2 项

设置提升方向
MDRB
Chinese Medicine · 2024 · IF 5.3

An integrated approach for studying exposure, metabolism, and disposition of traditional Chinese medicine using PATBS and MDRB tools: a case study of semen Armeniacae Amarum

Dandan Zhang,Junyu Zhang,Simian Chen,Hairong Zhang,Yuexin Yang,Shan Jiang,Yun Hong,Mingshe Zhu,Qiang Xie,Caisheng Wu

Background Deciphering the in vivo processes of traditional Chinese medicine (TCM) is crucial for identifying new pharmacodynamic substances and new drugs. Due to the complexity and diversity of components, investigating the exposure, metabolism, and disposition remains a major challenge in TCM research. In recent years, a number of non-targeted smart mass-spectrometry (MS) techniques, such as precise-and-thorough background-subtraction (PATBS) and metabolomics, have realized the intelligent identification of in vivo components of TCM. However, the metabolites characterization still largely relies on manual identification in combination with online databases. Results We developed a scoring approach based on the structural similarity and minimal mass defect variations between metabolites and prototypes. The current method integrates three dimensions of mass spectral data including m/z , mass defect of MS1 and MS2, and the similarity of MS2 fragments, which was sequentially analyzed by a R-based mass dataset relevance bridging (MDRB) data post-processing technique. The MDRB technology constructed a component relationship network for TCM, significantly improving metabolite identification efficiency and facilitating the mapping of translational metabolic pathways. By combining MDRB with PATBS through this non-targeted identification technology, we developed a comprehensive strategy for identification, characterization and bridging analysis of TCM metabolite in vivo. As a proof of concept, we adopted the proposed strategy to investigate the process of exposure, metabolism, and disposition of Semen Armeniacae Amarum (CKXR) in mice. Significance The currently proposed analytical approach is universally applicable and demonstrates its effectiveness in analyzing complex components of TCMs in vitro and in vivo. Furthermore, it enables the correlation of in vitro and in vivo data, providing insights into the metabolic transformations among components sharing the same parent nucleus structure. Finally, the developed MDRB platform is publicly available for ( https://github.com/933ZhangDD/MDRB ) for accelerating TCM research for the scientific community. Graphical

CAS / MDL: 9041-08-1
研究领域: 药理学 · 分析化学 · 生物信息学 · 药物化学
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Acta Pharmaceutica Sinica B · 2026 · IF 14.6

Deep MDRB: An integrated platform enabling high-coverage in vivo metabolite annotation in natural medicines

Jingjing Shi,Junyu Zhang,Xuting Zhou,Dandan Zhang,Hui Qi,Simian Chen,Yunlong Hou,Zhenhua Jia,Caisheng Wu

Comprehensive identification of in vivo metabolites from natural medicines (NMs) remains challenging due to their chemical complexity and the limited reference spectra. Here, we presented the deep mass dataset relevance bridging (Deep MDRB) platform, an integrated platform powered by a diagnostic weighted cosine similarity (DWCS) algorithm that efficiently facilitates high-coverage annotation of in vivo metabolites. By integrating mass spectral databases with biosynthetic and metabolic reaction rules, Deep MDRB enables fully automated non-targeted analysis, including peak extraction, background correction, multimodal data alignment, multilevel similarity matching, and parent–metabolite network bridging. As a proof of concept, Deep MDRB was applied to in vitro liver microsome models of verapamil and berberine, as well as an in vivo metabolic study involving mixed reference standards (MRS) and Tongxinluo (TXL) capsule in rats. The platform identified 1565 parent compounds with a 94.4% identification rate for the TXL capsule and constructed a biotransformation network of 29 in vitro , 83 (MRS) and 2069 (TXL capsule) in vivo metabolite nodes, respectively, with a correlation rate exceeding 90%. Compared to existing software, Deep MDRB substantially improves annotation coverage and network integrity. Overall, the “knowledge-data” dual-driven framework of Deep MDRB provides a novel strategy for metabolite profiling in complex systems.

CAS / MDL: 9041-08-1
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
已复制

文献关联基于可获得的产品、CAS、DOI 及引用记录。收录不代表作者或出版方对阿拉丁产品的背书,请以原始文献为准。